"In recent years pharmaceutical, biotechnology, and medical device industries have experienced significant issues with data integrity worldwide, impacting the veracity and quality of the data on which a regulatory decision is based which ultimately affects patient safety," said John Bournas, ISPE CEO and President. "This Guide integrates Cultural Excellence and critical thinking skills into data integrity practices to aid companies in meeting regulatory requirements and expectations."